MOLECULAR CANCER RESEARCH

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; and signal transduction), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.Molecular Cancer Research accepts submissions of primary research, review and commentary article types as well as letters to the editor. For descriptions and length requirements of the article types available to submitting authors see the Categories of Articles for Molecular Cancer Research. The AACR Journals all use a similar Editorial Process. Please note that Molecular Cancer Research does not consider appeals.Submitting authors must be familiar with the Editorial Policies of the AACR Journals covering important information on authorship, publishing ethics, availability of materials and data and data analysis and reporting.Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly-significant research are accepted for publication.

分子癌症研究发表文章描述了对该领域有广泛兴趣的新的基础癌症研究发现。研究必须具有证明意义，并且该杂志将分子和细胞水平的分析放在首位，揭示了与癌症风险、发展和/或进展相关的途径和过程的新的机械洞察。重点领域包括所有癌症相关途径（包括细胞周期调节、细胞死亡、染色质调节、DNA损伤和修复、基因和RNA调节、基因组学、癌基因和肿瘤抑制因子以及信号转导），以及描述支持癌症表型的新分子机制和相互作用的研究。为了充分考虑，提交的初步研究必须提供对现有通路功能的重要新见解，或解决与癌症相关的生物学问题相关的新假设。分子癌症研究接受提交的初步研究，评论和评论文章类型以及给编辑的信件。有关提交给作者的文章类型的描述和长度要求，请参阅分子癌症研究的文章类别。AACR期刊都使用类似的编辑过程。请注意，分子癌症研究不考虑上诉。提交作者必须熟悉AACR期刊的编辑政策，包括关于作者身份、出版道德、材料和数据的可用性以及数据分析和报告的重要信息。对手稿进行严格的审查，以获得高标准的科学价值，只有那些报告小说、及时和广泛重要研究成果的手稿才被接受出版。